QuickView for TORC2 signaling (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
3. Gene expression patterns associated with recurrent chromosomal translocations in ALL
4. Astrocyte and oligodendrocyte precursors and neural stem cells with HRas[L61] overexpression
5. Liver and muscle gene expression in mice selected for high and low body weights

There were no matches for TORC2 signaling

1. Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer
2. Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration